Sign in

CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464670809
Phone
(650) 900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. 8-K Event Executive or director change
  9. 4 Open-market buy Director bought 21,700 shares at $11.53 ($250,236)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 8-K Event Shareholder vote results
  15. 4 Open-market buy President and CEO bought 6,932 shares at an average $12.04 ($83,453)
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. 8-K Event Regulation FD disclosure · Other events
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. 10-Q Report Quarterly Report

Page 1 of 30 · 584 filings